Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Molecular Imaging and Biology | journal | 1.067 Q3 | 78 | 90 | 313 | 2949 | 1081 | 303 | 3.40 | 32.77 | 31.05 | |
52 | Nutrition and Cancer | journal | 1.061 Q3 | 130 | 170 | 419 | 8012 | 1433 | 414 | 3.07 | 47.13 | 47.91 | |
53 | Cancer genetics | journal | 1.060 Q3 | 52 | 57 | 191 | 2196 | 467 | 181 | 2.45 | 38.53 | 52.96 | |
54 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 1.005 Q3 | 90 | 129 | 335 | 3929 | 827 | 318 | 2.26 | 30.46 | 31.23 | |
55 | Medical Oncology | journal | 0.902 Q3 | 90 | 434 | 1136 | 12797 | 2587 | 1107 | 2.34 | 29.49 | 40.01 | |
56 | Cancer Genetics and Cytogenetics | journal | 0.900 Q3 | 78 | 0 | 246 | 0 | 490 | 210 | 0.00 | 0.00 | 0.00 | |
57 | Nuclear Medicine and Biology | journal | 0.874 Q3 | 98 | 140 | 402 | 4834 | 1098 | 392 | 2.65 | 34.53 | 31.50 | |
58 | Anti-Cancer Drugs | journal | 0.836 Q3 | 102 | 125 | 395 | 4921 | 997 | 387 | 2.26 | 39.37 | 38.14 | |
59 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.797 Q3 | 65 | 151 | 296 | 4365 | 608 | 285 | 2.16 | 28.91 | 41.05 | |
60 | Technology in Cancer Research and Treatment | journal | 0.785 Q3 | 72 | 60 | 193 | 1870 | 500 | 182 | 2.22 | 31.17 | 31.30 | |
61 | Oncogenesis | journal | 0.765 Q3 | 67 | 45 | 34 | 2105 | 45 | 33 | 1.32 | 46.78 | 41.74 | |
62 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.738 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
63 | Current Problems in Cancer | journal | 0.659 Q3 | 47 | 30 | 78 | 1853 | 94 | 58 | 0.64 | 61.77 | 50.00 | |
64 | Oncology Research | journal | 0.600 Q3 | 76 | 67 | 116 | 2001 | 197 | 116 | 1.62 | 29.87 | 31.44 | |
65 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.592 Q3 | 68 | 98 | 272 | 3422 | 512 | 262 | 1.68 | 34.92 | 39.61 | |
66 | Journal of Experimental Therapeutics and Oncology | journal | 0.501 Q3 | 40 | 11 | 74 | 158 | 100 | 69 | 1.39 | 14.36 | 29.63 | |
67 | Oncology | journal | 0.435 Q3 | 83 | 248 | 746 | 4354 | 537 | 533 | 0.70 | 17.56 | 32.12 | |
68 | National Toxicology Program technical report series | journal | 0.170 | 22 | 4 | 28 | 0 | 18 | 28 | 0.53 | 0.00 | 66.67 | |
69 | Current Cancer Research | book series | 0.164 Q4 | 8 | 0 | 65 | 0 | 24 | 62 | 0.37 | 0.00 | 0.00 | |
70 | Journal of Cancer Science and Therapy (discontinued) | journal | 0.158 Q4 | 22 | 78 | 187 | 3112 | 84 | 171 | 0.39 | 39.90 | 35.11 | |
71 | Cancer Therapy | journal | 0.136 Q4 | 9 | 9 | 23 | 419 | 14 | 23 | 2.00 | 46.56 | 41.38 | |
72 | Annals of Cancer Research and Therapy | journal | 0.115 Q4 | 7 | 5 | 37 | 95 | 5 | 37 | 0.09 | 19.00 | 12.50 | |
73 | Cancer Immunology Research | journal | 134 | 68 | 30 | 787 | 112 | 29 | 2.10 | 11.57 | 35.21 | ||
74 | Cancer journal (Sudbury, Mass.) | journal | 102 | 74 | 261 | 4493 | 1132 | 234 | 4.06 | 60.72 | 39.44 | ||
75 | Current Pathobiology Reports | journal | 33 | 33 | 0 | 2872 | 0 | 0 | 0.00 | 87.03 | 37.65 | ||
76 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 13 | 35 | 1797 | 126 | 35 | 3.71 | 138.23 | 47.46 | ||
77 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 28 | 749 | 0 | 28 | 0.00 | 187.25 | 0.00 | ||
78 | Report on carcinogens. Monograph on .. | book series | 2 | 2 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®